(Circulation. 1996;93:1651-1657.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Cardiology and Department of Clinical Chemistry, University of Uppsala, Sweden.
Correspondence to Bertil Lindahl, MD, Department of Cardiology, University Hospital, S-751 85 Uppsala, Sweden. E-mail lars.wallentin@thorax.uas.se; E-mail helene.strombom@thorax.uas.se.
Background Early risk assessment is important in patients with unstable coronary artery disease, ie, unstable angina or nonQ-wave myocardial infarction. Some previous small studies have indicated that patients with unstable angina and elevation of troponin T (tn-T) have worse short-term and long-term prognoses. In this study, the prognostic value of tn-T was evaluated and compared with other early available risk indicators.
Methods and Results Nine hundred seventy-six patients
participating in a randomized study of low-molecular-weight
heparin in unstable coronary artery disease were followed for 5
months after the index episode. The risk of cardiac events increased
with increasing maximal levels of tn-T obtained in the initial 24
hours. The lowest quintile (<0.06 µg/L) constituted a low-risk
group, the second quintile (0.06 to 0.18 µg/L) an
intermediate-risk group, and the three highest quintiles (
0.18
µg/L) a high-risk group, with 4.3%, 10.5%, and 16.1% risk of
either myocardial infarction or cardiac death, respectively. Troponin T
level was identified together with age, hypertension, number of
antianginal drugs, and ECG changes at rest as independent prognostic
variables for myocardial infarction or cardiac death in a
multivariate analysis. The prognostic value of
tn-T was independent of the classification of index event into unstable
angina or myocardial infarction.
Conclusions Troponin T determination is an inexpensive and widely applicable method for early risk assessment in patients with unstable coronary artery disease. The maximum tn-T value obtained during the first 24 hours provides independent and important prognostic information.
Key Words: coronary disease prognosis heparin myocardial infarction
This article has been cited by other articles:
![]() |
K. M. Eggers, B. Lagerqvist, P. Venge, L. Wallentin, and B. Lindahl Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality Circulation, October 23, 2007; 116(17): 1907 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shah, J. Selter, Y. Wang, M. Greenspan, and J. M. Foody Association of Troponin Status With Guideline-Based Management of Acute Myocardial Infarction in Older Persons Arch Intern Med, August 13, 2007; 167(15): 1621 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yee-Moon Wang, C. Wai-Kei Lam, M. Wang, I. Hiu-Shuen Chan, W. B. Goggins, C.-M. Yu, S.-F. Lui, and J. E Sanderson Prognostic Value of Cardiac Troponin T Is Independent of Inflammation, Residual Renal Function, and Cardiac Hypertrophy and Dysfunction in Peritoneal Dialysis Patients Clin. Chem., May 1, 2007; 53(5): 882 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Circulation, April 3, 2007; 115(13): e356 - e375. [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Clin. Chem., April 1, 2007; 53(4): 552 - 574. [Full Text] [PDF] |
||||
![]() |
R. Bugiardini, O. Manfrini, and G. M. De Ferrari Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med, July 10, 2006; 166(13): 1391 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. James, M. Flodin, N. Johnston, B. Lindahl, and P. Venge The Antibody Configurations of Cardiac Troponin I Assays May Determine Their Clinical Performance Clin. Chem., May 1, 2006; 52(5): 832 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zethelius, N. Johnston, and P. Venge Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study Circulation, February 28, 2006; 113(8): 1071 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Conway, M. McLaughlin, P. Sharpe, and J. Harty Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2759 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Devlin, F A Anderson, S Heald, J Lopez-Sendon, A Avezum, J Elliott, O H Dabbous, D Brieger, and for the GRACE Investigators Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry Heart, November 1, 2005; 91(11): 1394 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Wang, C.-F. Feng, T.-K. Er, L.-Y. Tsai, C.-Y. Chen, S.-J. Chang, and B.-H. Chen Comparison of Cardiac Troponin I Levels in Serum and Sodium-Citrate Plasma Using the ACCESS 2 Immunoassay Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 453 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Roe, E. D. Peterson, Y. Li, C. V. Pollack Jr, R. H. Christenson, W. F. Peacock, F. M. Fesmire, L. K. Newby, R. L. Jesse, J. W. Hoekstra, et al. Relationship Between Risk Stratification by Cardiac Troponin Level and Adherence to Guidelines for Non-ST-Segment Elevation Acute Coronary Syndromes Arch Intern Med, September 12, 2005; 165(16): 1870 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Nageh, R A Sherwood, B M Harris, and M R Thomas Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease Heart, September 1, 2005; 91(9): 1181 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Khavandi, N P Jenkins, H S Lee, and M Gavalas Misdiagnosis of myocardial infarction by troponin I following minor blunt chest trauma Emerg. Med. J., August 1, 2005; 22(8): 603 - 604. [Full Text] [PDF] |
||||
![]() |
P. de Araujo Goncalves, J. Ferreira, C. Aguiar, and R. Seabra-Gomes TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS Eur. Heart J., May 1, 2005; 26(9): 865 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cook, D. Taylor, M. France, G. Burrows, E. Manning, G. Lyratzopoulos, P. McElduff, P. Lewis, M. Martin, and R.F. Heller Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarction QJM, April 1, 2005; 98(4): 275 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
G A Large Contemporary management of acute coronary syndrome Postgrad. Med. J., April 1, 2005; 81(954): 217 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J Knight, T R Keeble, S Wilson, J Cooper, A Deaner, K Ranjadayalan, and A D Timmis Short term prognosis of patients with acute coronary syndromes: the level of cardiac troponin T elevation corresponding to the "old" WHO definition of myocardial infarction Heart, March 1, 2005; 91(3): 373 - 374. [Full Text] [PDF] |
||||
![]() |
N Curzen Troponin in patients with chest pain BMJ, December 11, 2004; 329(7479): 1357 - 1358. [Full Text] [PDF] |
||||
![]() |
A. I. Larsen and K. Dickstein BNP in acute coronary syndromes: the heart expresses its suffering Eur. Heart J., August 1, 2004; 25(15): 1284 - 1286. [Full Text] [PDF] |
||||
![]() |
S. J. Howell and J. W. Sear Perioperative myocardial injury: individual and population implications Br. J. Anaesth., July 1, 2004; 93(1): 3 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.A. Alhadi and K.A.A. Fox Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein QJM, April 1, 2004; 97(4): 187 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kontos, R. Shah, L. M. Fritz, F. P. Anderson, J. L. Tatum, J. P. Ornato, and R. L. Jesse Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients J. Am. Coll. Cardiol., March 17, 2004; 43(6): 958 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Myhre, R. Stenseth, A. Karevold, L. Bjella, P. S. Lingaas, P. O. Olsen, R. Haaverstad, I. Kirkeby-Garstad, and O. Walle Levang Bleeding Following Coronary Surgery After Preoperative Low-Molecular-Weight Heparin Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 3 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okamatsu, M. Takano, S. Sakai, F. Ishibashi, R. Uemura, T. Takano, and K. Mizuno Elevated Troponin T Levels and Lesion Characteristics in Non-ST-Elevation Acute Coronary Syndromes Circulation, February 3, 2004; 109(4): 465 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. White and J. K. French Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1917 - 1920. [Full Text] [PDF] |
||||
![]() |
J Trevelyan, E W A Needham, S C H Smith, and R K Mattu Sources of diagnostic inaccuracy of conventional versus new diagnostic criteria for myocardial infarction in an unselected UK population with suspected cardiac chest pain, and investigation of independent prognostic variables Heart, December 1, 2003; 89(12): 1406 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Luepker, F. S. Apple, R. H. Christenson, R. S. Crow, S. P. Fortmann, D. Goff, R. J. Goldberg, M. M. Hand, A. S. Jaffe, D. G. Julian, et al. Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies: A Statement From the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation, November 18, 2003; 108(20): 2543 - 2549. [Full Text] [PDF] |
||||
![]() |
P. Venge, N. Johnston, B. Lagerqvist, L. Wallentin, and B. Lindahl Clinical and Analytical Performance of the Liaison Cardiac Troponin I Assay in Unstable Coronary Artery Disease, and the Impact of Age on the Definition of Reference Limits. A FRISC-II Substudy Clin. Chem., June 1, 2003; 49(6): 880 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Scott, A. Deman, P. Peeters, C. Van den Branden, J.-C. Stolear, G. Van Camp, and D. Verbeelen Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients Nephrol. Dial. Transplant., April 1, 2003; 18(4): 737 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
I P Casserly and E J Topol The primacy of clinical effectiveness for cost effectiveness analysis Heart, March 1, 2003; 89(3): 249 - 250. [Full Text] [PDF] |
||||
![]() |
P O Collinson, P J Stubbs, and A-C Kessler Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice Heart, March 1, 2003; 89(3): 280 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Newby, B. U. Goldmann, and E. M. Ohman Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 31S - 36S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kaul, L. K. Newby, Y. Fu, V. Hasselblad, K. W. Mahaffey, R. H. Christenson, R. A. Harrington, E. M. Ohman, E. J. Topol, R. M. Califf, et al. Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients J. Am. Coll. Cardiol., February 5, 2003; 41(3): 371 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Miller, K Lipscomb, and N Curzen Are district general hospital patients with unstable angina at a disadvantage? Postgrad. Med. J., February 1, 2003; 79(928): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bertrand, M. L. Simoons, K. A.A. Fox, L. C. Wallentin, C. W. Hamm, E. McFadden, P. J. De Feyter, G. Specchia, and W. Ruzyllo Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur. Heart J., December 1, 2002; 23(23): 1809 - 1840. [Full Text] [PDF] |
||||
![]() |
C. Lowbeer, A. Gutierrez, S. A. Gustafsson, R. Norrman, J. Hulting, and A. Seeberger Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2178 - 2183. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Sheridan and D C Crossman Critical review of unstable angina and non-ST elevation myocardial infarction Postgrad. Med. J., December 1, 2002; 78(926): 717 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Panteghini Acute Coronary Syndrome: Biochemical Strategies in the Troponin Era Chest, October 1, 2002; 122(4): 1428 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Laarse Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure Cardiovasc Res, October 1, 2002; 56(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Konstantinides, A. Geibel, M. Olschewski, W. Kasper, N. Hruska, S. Jackle, and L. Binder Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary Embolism Circulation, September 3, 2002; 106(10): 1263 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Meier, W. H. Al-Badr, J. V. Cooper, E. M. Kline-Rogers, D. E. Smith, K. A. Eagle, and R. H. Mehta The New Definition of Myocardial Infarction: Diagnostic and Prognostic Implications in Patients With Acute Coronary Syndromes Arch Intern Med, July 22, 2002; 162(14): 1585 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.R. Ferreiros, R. Kevorkian, J.J. Fuselli, J. Guetta, C.P. Boissonnet, D. di Toro, R. Cragnolino, O. Masoli, A. Cagide, and J. Krauss First national survey on management strategies in non ST-elevation acute ischaemic syndromes in Argentina. Results of the STRATEG-SIA study Eur. Heart J., July 1, 2002; 23(13): 1021 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J McKenna and J C. Forfar Was it a heart attack? BMJ, February 16, 2002; 324(7334): 377 - 378. [Full Text] [PDF] |
||||
![]() |
S. Savonitto, C. B. Granger, D. Ardissino, L. Gardner, C. Cavallini, M. Galvani, F. Ottani, H. D. White, P. W. Armstrong, E. M. Ohman, et al. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes J. Am. Coll. Cardiol., January 2, 2002; 39(1): 22 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.J. Alp, J.A. Bell, and M. Shahi A rapid troponin-I-based protocol for assessing acute chest pain QJM, December 1, 2001; 94(12): 687 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M. Akkerhuis, P.A.J. Klootwijk, W. Lindeboom, V.A.W.M. Umans, S. Meij, P.-P. Kint, and M.L. Simoons Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients Eur. Heart J., November 1, 2001; 22(21): 1997 - 2006. [Abstract] [PDF] |
||||
![]() |
B. Lindahl, E. Diderholm, B. Lagerqvist, P. Venge, L. Wallentin, and the FRISC II Investigators Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy J. Am. Coll. Cardiol., October 1, 2001; 38(4): 979 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Heidenreich, T. Alloggiamento, K. Melsop, K. M. McDonald, A. S. Go, and M. A. Hlatky The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis J. Am. Coll. Cardiol., August 1, 2001; 38(2): 478 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Venge, B. Lindahl, and L. Wallentin New Generation Cardiac Troponin I Assay for the Access Immunoassay System Clin. Chem., May 1, 2001; 47(5): 959 - 961. [Full Text] [PDF] |
||||
![]() |
C.W. Hamm GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection Eur. Heart J. Suppl., May 1, 2001; 3(suppl_A): A14 - A20. [Abstract] [PDF] |
||||
![]() |
A M Huggon, J Chambers, N Nayeem, P Tutt, M Crook, and S Swaminathan Biochemical markers in the management of suspected acute myocardial infarction in the emergency department Emerg. Med. J., January 1, 2001; 18(1): 15 - 19. [Abstract] [Full Text] |
||||
![]() |
A. Manhapra and S. Borzak Regular review: Treatment possibilities for unstable angina BMJ, November 18, 2000; 321(7271): 1269 - 1275. [Full Text] |
||||
![]() |
J. E. Calvin, L. W. Klein, E. J. VandenBerg, P. Meyer, and J. E. Parrillo Validated risk stratification model accurately predicts low risk in patients with unstable angina J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1803 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kontos, F. P. Anderson, R. Alimard, J. P. Ornato, J. L. Tatum, and R. L. Jesse Ability of troponin I to predict cardiac events in patients admitted from the emergency department J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1818 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. de Winter Risk stratification with cardiac troponin I in acute coronary syndromes J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1824 - 1826. [Full Text] [PDF] |
||||
![]() |
E. Giannitsis, S. Lehrke, U. K. H. Wiegand, V. Kurowski, M. Muller-Bardorff, B. Weidtmann, G. Richardt, and H. A. Katus Risk Stratification in Patients With Inferior Acute Myocardial Infarction Treated by Percutaneous Coronary Interventions : The Role of Admission Troponin T Circulation, October 24, 2000; 102(17): 2038 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lindahl, H. Toss, A. Siegbahn, P. Venge, L. Wallentin, and The FRISC Study Group Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease N. Engl. J. Med., October 19, 2000; 343(16): 1139 - 1147. [Abstract] [Full Text] [PDF] |
||||